Takeda Pharmaceutical Company Limited logo
Takeda Pharmaceutical Company Limited TAK
$ 14.09 0.93%

Quarterly report 2022-Q1
added 06-29-2022

report update icon

Takeda Pharmaceutical Company Limited Financial Statements 2011-2024 | TAK

Annual Financial Statements Takeda Pharmaceutical Company Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

20.3 B 56.2 B 35.2 B 33.1 B 38.8 B 37.6 B 40.4 B 35.3 B 43 B 34.3 B 38.3 B

Shares

1.56 B 3.13 B 1.92 B 1.56 B 1.56 B 1.57 B 1.57 B 1.58 B 1.58 B 1.58 B 1.58 B

Historical Prices

13.6 18.2 18.8 15.3 25 17.7 20.6 16.6 17.8 16.5 15.7

Net Income

376 B 44.2 B 109 B 187 B 115 B 80.2 B -146 B 107 B 131 B 124 B 248 B

Revenue

3.2 T 3.29 T 2.1 T 1.77 T 1.73 T 1.81 T 1.78 T 1.69 T 1.56 T 1.51 T 1.42 T

Cost of Revenue

994 B 1.09 T 652 B 496 B 559 B - - - - - -

Gross Profit

- 2.2 T 1.44 T 1.27 T 1.17 T 1.27 T 1.26 T 1.2 T 1.11 T 1.08 T 1.1 T

Operating Income

509 B 100 B 238 B 242 B 156 B - - - - - -

Interest Expense

131 B 149 B 48.2 B 10 B 7.56 B - - - - - -

EBITDA

509 B 722 B 358 B 364 B 313 B 256 B 47.1 B 282 B 324 B 415 B 474 B

Operating Expenses

- 1.94 T 1.28 T 1.03 T 1.02 T 1.14 T 1.39 T 1.06 T 987 B 811 B 735 B

General and Administrative Expenses

- 965 B 718 B 628 B 619 B 651 B 613 B 556 B 812 B 811 B 640 B

All numbers in JPY currency

Quarterly Income Statement Takeda Pharmaceutical Company Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in JPY currency